You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 4, April 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psychotropic Drug Use in the Boston Area

A Report From the Boston Collaborative Drug Surveillance Program

David J. Greenblatt, MD; Richard I. Shader, MD; Jan Koch-Weser, MD

Arch Gen Psychiatry. 1975;32(4):518-521.


Abstract

During 1972, adults admitted to general medical and surgical wards in Boston area hospitals were interviewed to determine their use of prescribed psychotropic drugs prior to hospitalization. Patients hospitalized for psychiatric disorders or psychogenic ("functional") disease were excluded. Patients who had taken prescribed drugs that could not be identified were considered nonusers.

Of the total sample, 20% gave a history of psychotropic drug use. Antianxiety drugs were taken by 15% of the patients and accounted for two thirds of total psychotropic drug use. Hypnotics were taken by another 4% of the sample. Slightly over half of antianxiety and hypnotic drug use was for a year or more. Use was more frequent in patients with potentially chronic medical disorders. The findings, in general, are consistent with other studies employing other methods to investigate the use of psychotropic drugs. Simple studies of use, however, do not provide a sole or adequate definition of treatment option, need, or efficacy.



Author Affiliations

From the Boston Collaborative Drug Surveillance Program, Boston University Medical Center; the Clinical Pharmacology Unit, Massachusetts General Hospital (Drs. Greenblatt and Koch-Weser); and the Psychopharmacology Research Laboratory, Massachusetts Mental Health Center and Harvard Medical School (Dr. Shader).


Footnotes

Accepted for publication Oct 21, 1974.

Reprint requests to the Boston Collaborative Drug Surveillance Program, 400 Totten Pond Rd, Waltham, MA 02154 (Dr. Greenblatt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Withdrawal Reaction From Long-term, Low-dosage Administration of Diazepam: A Double-blind, Placebo-Controlled Case Study
Winokur et al.
Arch Gen Psychiatry 1980;37:101-105.
ABSTRACT  

Hospital Surveys of Prescribing Practices With Psychotherapeutic Drugs: A Critical Examination
Prien et al.
Arch Gen Psychiatry 1978;35:1271-1275.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.